4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-17-037302
CIK 0001328143operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:40 PM ET
Size
9.0 KB
Accession
0001209191-17-037302
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-01+15,000→ 15,000 totalExercise: $16.27Exp: 2027-05-31→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 1, 2017, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:40 PM ET
- Size
- 9.0 KB